{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:07:19Z","timestamp":1768410439198,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cger.2025.01.003","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T08:37:37Z","timestamp":1741250257000},"page":"175-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["New Paradigms for Bladder Cancer Management in Geriatrics"],"prefix":"10.1016","volume":"41","author":[{"given":"Landan","family":"MacDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly K.","family":"Bree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cger.2025.01.003_bib2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3","article-title":"The National Cancer Data base report on bladder carcinoma","volume":"78","author":"Fleshner","year":"1996","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.eururo.2009.05.008","article-title":"Complications following radical cystectomy for bladder cancer in the elderly","volume":"56","author":"Froehner","year":"2009","journal-title":"Eur Urol"},{"issue":"10206","key":"10.1016\/j.cger.2025.01.003_bib4","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(19)31785-4","article-title":"Management of frailty: opportunities, challenges, and future directions","volume":"394","author":"Dent","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cger.2025.01.003_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jgs.17468","article-title":"Life expectancy estimates based on comorbidities and frailty to inform preventive care","volume":"70","author":"Schoenborn","year":"2022","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.cger.2025.01.003_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12877-022-02876-0","article-title":"Do changes in frailty, physical functioning, and cognitive functioning predict mortality in old age? Results from the Longitudinal Aging Study Amsterdam","volume":"22","author":"Kusumastuti","year":"2022","journal-title":"BMC Geriatr"},{"issue":"8","key":"10.1016\/j.cger.2025.01.003_bib7","first-page":"1347","article-title":"Feature selection algorithms enhance the accuracy of frailty indexes as measures of biological age","volume":"76","author":"Kim","year":"2021","journal-title":"J\u00a0Gerontol"},{"issue":"4","key":"10.1016\/j.cger.2025.01.003_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4997\/JRCPE.2012.412","article-title":"Frailty and its quantitative clinical evaluation","volume":"42","author":"Moorhouse","year":"2012","journal-title":"J\u00a0R Coll Physicians Edinb"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib9","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J\u00a0Geronotol A Biol Med Sci"},{"key":"10.1016\/j.cger.2025.01.003_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2024.06.004","article-title":"Clinical validation of the intermediate-risk non\u2013muscle-invasive bladder cancer scoring system and substratification model proposed by the international bladder cancer group: a multicenter young academic urologists urothelial working group collaboration","author":"Soria","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.cger.2025.01.003_bib11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.euo.2024.01.011","article-title":"Association of age with non\u2013muscle-invasive bladder cancer: unearthing a biological basis for epidemiological disparities?","volume":"7","author":"Lobo","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic burden of bladder cancer across the European union","volume":"69","author":"Leal","year":"2016","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.cger.2025.01.003_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.euo.2019.01.015","article-title":"The cost to Medicare of bladder cancer care","volume":"3","author":"Sloan","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.cger.2025.01.003_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks","volume":"70","author":"Cumberbatch","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ije\/dyw044","article-title":"Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies","volume":"45","author":"Van Osch","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"16","key":"10.1016\/j.cger.2025.01.003_bib17","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.3390\/cancers14164022","article-title":"Prognostic impact of post-diagnosis smoking cessation among bladder cancer patients: a systematic literature review and meta-analysis","volume":"14","author":"Caini","year":"2022","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.cger.2025.01.003_bib18","first-page":"1871","article-title":"Impact of a bladder cancer diagnosis on smoking behavior","volume":"30","author":"Bassett","year":"2012","journal-title":"J\u00a0Clin Orthod"},{"key":"10.1016\/j.cger.2025.01.003_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.urology.2020.12.033","article-title":"Prevalence and correlates of successful smoking cessation in bladder cancer survivors","volume":"153","author":"Bassett","year":"2021","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib20","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.eururo.2012.11.039","article-title":"Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy","volume":"64","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.cger.2025.01.003_bib21","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.eururo.2012.08.025","article-title":"Impact of smoking and smoking cessation on oncologic outcomes in primary non\u2013muscle-invasive bladder cancer","volume":"63","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"issue":"5\u20136","key":"10.1016\/j.cger.2025.01.003_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000507122","article-title":"Does smoking cessation at primary diagnosis reduce the recurrence risk of nonmuscle-invasive bladder cancer? Results of a prospective study","volume":"104","author":"Serretta","year":"2020","journal-title":"Urol Int"},{"issue":"6S","key":"10.1016\/j.cger.2025.01.003_bib23","first-page":"2473","article-title":"Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline","volume":"188","author":"Davis","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.cger.2025.01.003_bib24","first-page":"422","article-title":"Haematuria investigation based on a standard protocol: emphasis on the diagnosis of urological malignancy","volume":"47","author":"Alishahi","year":"2002","journal-title":"J\u00a0R Coll Surg Edinb"},{"issue":"2","key":"10.1016\/j.cger.2025.01.003_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.mayocpiqo.2020.12.001","article-title":"Cancer prevalence and risk stratification in adults presenting with hematuria: a population-based cohort study","volume":"5","author":"Takeuchi","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"5","key":"10.1016\/j.cger.2025.01.003_bib26","first-page":"973","article-title":"Can renal and bladder ultrasound replace computerized tomography urogram in patients investigated for microscopic hematuria?","volume":"200","author":"Tan","year":"2018","journal-title":"J\u00a0Urol"},{"issue":"602","key":"10.1016\/j.cger.2025.01.003_bib27","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.3399\/bjgp12X654560","article-title":"Clinical features of bladder cancer in primary care","volume":"62","author":"Shephard","year":"2012","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cger.2025.01.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2020-4-13","article-title":"Urinary tract infections in the elderly: a review of disease characteristics and current treatment options","volume":"9","author":"Rodriguez-Ma\u00f1as","year":"2020","journal-title":"Drugs Context"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00261-017-1249-6","article-title":"Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results","volume":"43","author":"Trinh","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.cger.2025.01.003_bib30","unstructured":"Staheli B and Rondeau B. Anesthetic considerations in the geriatric population. [Updated 2023 Aug 5]. In: StatPearls [Internet], 2025, StatPearls Publishing, Treasure Island (FL). Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572137\/ (Accessed 9 October 2024)."},{"issue":"2","key":"10.1016\/j.cger.2025.01.003_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4097\/kja.19437","article-title":"Anesthetic considerations for urologic surgeries","volume":"73","author":"Koo","year":"2020","journal-title":"Korean J Anesthesiol"},{"issue":"9","key":"10.1016\/j.cger.2025.01.003_bib32","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s11255-023-03638-6","article-title":"Bladder perforation as a complication of transurethral resection of bladder tumors: the predictors, management, and its impact in a series of 1570 at a tertiary urology institute","volume":"55","author":"Osman","year":"2023","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1016\/j.cger.2025.01.003_bib33","first-page":"1566","article-title":"Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors","volume":"187","author":"Herkommer","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.cger.2025.01.003_bib34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.cger.2025.01.003_bib35","first-page":"1021","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3050","article-title":"Management, surveillance patterns, and costs associated with low-grade papillary stage Ta non\u2013muscle-invasive bladder cancer among older adults, 2004-2013","volume":"5","author":"Bree","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.cger.2025.01.003_bib37","first-page":"60","article-title":"Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome","volume":"163","author":"Herr","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.cger.2025.01.003_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.euf.2023.06.012","article-title":"Long-term recurrence rates of low-risk non\u2013muscle-invasive bladder cancer\u2014how long is cystoscopic surveillance necessary?","volume":"10","author":"Ma","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.cger.2025.01.003_bib39","article-title":"Deintensification of treatment for low-grade bladder tumors: a collaborative review by the international bladder cancer group (IBCG)","author":"Contieri","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.cger.2025.01.003_bib40","first-page":"1","article-title":"Non-muscle-invasive bladder cancer (TaT1 and CIS) EAU guidelines","volume":"31","year":"2023","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.cger.2025.01.003_bib41","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jgo.2020.02.001","article-title":"Management of bladder cancer in older patients: position paper of a SIOG Task Force","volume":"11","author":"Mottet","year":"2020","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"5","key":"10.1016\/j.cger.2025.01.003_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2006.05.003","article-title":"Aging and innate immunity","volume":"24","author":"Solana","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cger.2025.01.003_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2007.03.024","article-title":"Age and outcome of superficial bladder cancer treated with bacille Calmette-Gu\u00e9rin therapy","volume":"70","author":"Herr","year":"2007","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000496802","article-title":"Comparison of outcomes between standard and palliative management for high grade non-muscle invasive bladder cancer in patients older than 85 years","volume":"102","author":"Carrion","year":"2019","journal-title":"Urol Int"},{"issue":"1","key":"10.1016\/j.cger.2025.01.003_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bju.16127","article-title":"Impact of age\u00a0>70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette\u2013Gu\u00e9rin","volume":"133","author":"Contieri","year":"2024","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.cger.2025.01.003_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0849","article-title":"Comparison of sequential intravesical gemcitabine and docetaxel vs Bacillus Calmette-Gu\u00e9rin for the treatment of patients with high-risk non\u2013muscle-invasive bladder cancer","volume":"6","author":"McElree","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.cger.2025.01.003_bib47","first-page":"74","article-title":"Efficacy of intravesical Nadofaragene Firadenovec for patients with Bacillus Calmette-Gu\u00e9rin\u2013unresponsive nonmuscle-invasive bladder cancer: 5-year follow-up from a phase 3 trial","volume":"212","author":"Narayan","year":"2024","journal-title":"J\u00a0Urol"},{"issue":"7","key":"10.1016\/j.cger.2025.01.003_bib48","doi-asserted-by":"crossref","first-page":"344.e1","DOI":"10.1016\/j.urolonc.2022.02.009","article-title":"The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial","volume":"40","author":"Daneshmand","year":"2022","journal-title":"Urol Oncol"},{"issue":"8","key":"10.1016\/j.cger.2025.01.003_bib49","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1038\/s41591-024-03025-3","article-title":"Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial","volume":"30","author":"Li","year":"2024","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.cger.2025.01.003_bib50","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(21)00147-9","article-title":"Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study","volume":"22","author":"Balar","year":"2021","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.cger.2025.01.003_bib51","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/bjc.2013.106","article-title":"Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients","volume":"108","author":"Noon","year":"2013","journal-title":"Br J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.cger.2025.01.003_bib52","doi-asserted-by":"crossref","DOI":"10.4111\/icu.2016.57.S1.S26","article-title":"Treatment of bladder cancer in the elderly","volume":"57","author":"Erlich","year":"2016","journal-title":"Investig Clin Urol"},{"issue":"9","key":"10.1016\/j.cger.2025.01.003_bib53","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.urolonc.2020.01.003","article-title":"Risk stratification metrics for bladder cancer: Comprehensive Geriatric Assessments","volume":"38","author":"Gadzinski","year":"2020","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.urolonc.2008.04.016","article-title":"The impact of marriage on bladder cancer mortality","volume":"27","author":"Nelles","year":"2009","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.cger.2025.01.003_bib55","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/jamainternmed.2021.6588","article-title":"Association of social support with functional outcomes in older adults who live alone","volume":"182","author":"Shah","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"7","key":"10.1016\/j.cger.2025.01.003_bib56","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s11255-023-03609-x","article-title":"Ileal conduit versus single stoma uretero-cutanoustomy after radical cystectomy in patients \u2265 75 years; which technique is better? a prospective randomized comparative study","volume":"55","author":"Moeen","year":"2023","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"10.1016\/j.cger.2025.01.003_bib57","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/annonc\/mdu204","article-title":"Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice","volume":"25","author":"Booth","year":"2014","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib58","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/cncr.22031","article-title":"Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder","volume":"107","author":"Dash","year":"2006","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.cger.2025.01.003_bib59","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cger.2025.01.003_bib60","article-title":"Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma","author":"Apolo","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.cger.2025.01.003_bib61","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1200\/JCO.21.00138","article-title":"Immunotherapy in older adults with cancer","volume":"39","author":"Presley","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.cger.2025.01.003_bib62","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.cger.2025.01.003_bib63","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.eururo.2012.11.015","article-title":"Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the national cancer data base","volume":"63","author":"Gray","year":"2013","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.cger.2025.01.003_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2013.06.216","article-title":"Outcomes of selective bladder preservation in the elderly treated with conservative surgery and chemoradiation","volume":"87","author":"Clayman","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.cger.2025.01.003_bib65","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/SPC.0b013e3283552d19","article-title":"Metastatic bladder cancer: anything new?","volume":"6","author":"Calabr\u00f2","year":"2012","journal-title":"Curr Opin Support Palliat Care"},{"issue":"10","key":"10.1016\/j.cger.2025.01.003_bib66","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.cger.2025.01.003_bib67","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.21873\/anticanres.17161","article-title":"Enfortumab vedotin for elderly advanced urothelial carcinoma patients or those with a poor performance status","volume":"44","author":"Furubayashi","year":"2024","journal-title":"Anticancer Res"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069025000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069025000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:44:02Z","timestamp":1752623042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069025000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0749069025000035"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2025.01.003","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Paradigms for Bladder Cancer Management in Geriatrics","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2025.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}